Matthew Lyall, BSc

Associate, Market Access and Outcomes Strategy

BSc (hons), Biomedical Science
The University of Manchester, Manchester, UK

Matthew Lyall, BSc, works as a Health Outcomes Scientist at RTI HS in the Manchester office. Mr. Lyall joined RTI-HS as an intern and prior to joining RTI-HS, he completed an honors Bachelors of Science degree in Biomedical Sciences. While getting his degree, Mr. Lyall completed a lab-based research project in the Manchester Collaborative Centre for Inflammation Research. In this project, he contributed to cutting edge research that helped determine how a protein involved in initiating the inflammatory process is regulated by ubiquitination. Mr. Lyall has experience in contributing to systematic and targeted literature reviews, evidence-based value dossiers, slide sets, communication packages, and submissions for NICE and the NCPE. Mr. Lyall has been involved in projects in a range of therapeutic areas, including oncology, diabetes, age related macular degeneration, asthma, multiple sclerosis, Alzheimer’s disease and cytomegalovirus infection.